Skip to content

Clinical trials

Observational Thyroid Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Diseases Phase: Observational Clear all

164 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20051
20062
20073
20085
20092
20104
20114
20121
20133
20144
20153
201611
201713
20187
201911
202016
202113
202211
202312
202413
202512
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Unknown status42
Recruiting17
Not yet recruiting8
Terminated7
Withdrawn6
Enrolling by invitation5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University6
National Taiwan University Hospital4
Shanghai 6th People's Hospital4
Aristotle University Of Thessaloniki2
Assistance Publique - Hôpitaux de Paris2
Boston Medical Center2
Central Hospital, Nancy, France2
Centre Hospitalier Princesse Grace2
Ege University2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Diseases164
Thyroid Neoplasms22
Thyroid Nodule12
Hypothyroidism11
Neoplasms11
Hyperthyroidism9
Parathyroid Diseases9
Diabetes Mellitus8
Goiter8
Graves Disease5

Trials

Showing 51 to 75 of 164. Each trial links to its page on Pharma Observatory.

64 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.